As we all know that symbols play a very important part in medical device labeling, hence it is critical to know when the relevant standard undergoes changes.

If you are a medical device manufacturer or Innovator and want to know more about the latest version of the ISO 15223-1:2021, then, this article is for you! The ISO 15223-1 standard details the symbols to be present on the Medical Device label and it is recommended for Medical Device manufacturers to be in compliance with this standard and the country specific regulations and labeling requirements to sell devices in different worldwide markets seamlessly without any non-conformance. Let us have a look at the list of common questions that are being asked by the Medical Device manufacturers on the latest version (2021) of the ISO 15223-1 standard which was earlier in the 2016 version.

What is the deadline for Manufacturers to be in full compliance with the ISO 15223-1:2021 version?

This has been a concern for almost all the manufacturers when it comes to a specific date after which the 2016 version of the ISO 15223-1 will no longer be valid and replaced by the 2021 version. The answer to this question depends upon the regulatory authorities. It is noted that US FDA has already adopted the 2021 version of ISO 15223-1 as per the Recognized Consensus Standards database. Further, EU has also recognized the 2021 Version of ISO 15223-1 as per the list of Harmonized standards dated January 5, 2022. Talking about Health Canada, it is to be noted that Health Canada does not even recognize the 2016 version of ISO 15223-1 yet on their list of recognized standards effective May 7, 2021.

Is the “MD” symbol mandatory to be present on the label ?

As per Annex I of the EU MDR regulation, manufacturers have to indicate on the device label that the product is a medical device. Hence the “MD” symbol will be of great help for someone selling their products in the EU and other jurisdictions that recognize CE marking. Further, inserting an “MD” symbol is far easier than mentioning ‘medical device’ on the label as in the latter case, the manufacturer has to translate the label into many languages based on the EU jurisdictions in which the device is to be sold.

The ISO 15223-1:2021 version includes a “UDI” symbol. Is it needed to be put along with the UDI carrier on the Label ? 

This depends on the medical device manufacturer’s label. If the label contains more than one QR Code or bar code and it is difficult to tell which one is a UDI carrier then it will be better that the manufacturer uses the “UDI” symbol, besides the UDI carrier, for easier identification. Additionally, it depends on the regulatory authority whether they make it mandatory to use the “UDI” symbol.

What about the inclusion of the “Translation” symbol in the list of symbols within the IFU ?

The translation symbol shall be added to the manufacturer’s IFU only when the translated information is not controlled by the manufacturer i.e the translation activity is being outsourced to a sub-contractor. The name and address of the sub-contractor performing translation shall also be added on the manufacturer’s label along with the “translation” symbol. The translation symbol was introduced in the ISO 15223-1:2021 version in order for EU importers and distributors to be in compliance with Article 16 of the MDR. 

Is a Change Notification required to be submitted to the EU Notified Body for making changes to the Label ?

Yes, Labeling changes are considered significant as per MDCG 2020-3 Guidance for significant changes. 

Shall we wait for the EU to release the list of harmonized standards so as to start with the MDR/IVDR remediation process ?

We advise all the medical device manufactures not to wait for the EU to release the list of harmonized standards and start performing a gap analysis of the newly released standards so as to start complying with the latest requirements since the EU journal gets revised only a few times per year, while the standards can get updated at a faster rate and it is important to give yourselves ample of time to make the necessary updates such that there is no impact on the regular business and commercialization or sales of medical devices in the impacted markets.

Concerned about performing Gap Analysis and unsure how to plan a transition?

Don’t worry! Elexes team is here to help you. Our dedicated team has years of experience performing gap analysis and helping to be in compliance with the newly released version of the medical device standards. Please contact us via email jennifer@elexes.com or call +1 650-503-6615 for further details.

#elexes #healthcare #uvc #sterilization #iso13485 #medicaldevice #mdr #ivdr #eu #mdd

Share This: